Skip to main content
JOHNSON & JOHNSON logo

JOHNSON & JOHNSON — Investor Relations & Filings

Ticker · JNJ ISIN · US4781601046 LEI · 549300G0CFPGEF6X2043 US Manufacturing
Open in API
Filings indexed 3,142 across all filing types
Latest filing 2008-08-01 Regulatory Filings
Country US United States of America
Listing US JNJ

About JOHNSON & JOHNSON

https://www.jnj.com/

Johnson & Johnson is a healthcare company that operates through two primary segments: Innovative Medicine and MedTech. The Innovative Medicine division is focused on the research, development, and delivery of new treatments for complex diseases in areas such as oncology, immunology, neuroscience, and cardiopulmonary conditions. The MedTech segment develops and provides a broad portfolio of medical technologies and solutions. It innovates in fields including surgery, orthopaedics, vision, and interventional solutions, aiming to create smarter, less invasive, and more personalized healthcare treatments. The company's mission is to address significant health challenges through science-based innovation at the intersection of biology and technology.

Recent filings

Filing Released Lang Actions
EIGHT-K
Regulatory Filings Classification · 95% confidence The document is an Amendment No. 1 to a Form 8-K Current Report filed by Johnson & Johnson. It states that the amendment is solely to include a conformed signature on the electronic filing and does not modify the original disclosure. The original Form 8-K filed on July 15, 2008, included a press release announcing sales and earnings for the second quarter ended June 29, 2008, and supplementary sales data and condensed consolidated statement of earnings. The document itself is short (3312 characters) and primarily serves as an amendment to a previously filed 8-K, focusing on administrative correction (signature inclusion) rather than substantive financial data or report content. According to the rules, such filings that are amendments or certifications without substantive financial data should be classified as Regulatory Filings (RNS).
2008-08-01 English
PRIMARY DOCUMENT
Director's Dealing
2008-07-28 English
PRIMARY DOCUMENT
Director's Dealing
2008-07-22 English
Earnings Release 2008
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions that Johnson & Johnson issued a press release announcing sales and earnings for the second quarter ended June 29, 2008. The document includes a press release and unaudited supplementary sales data as exhibits. The length of the document is 2251 characters, which is relatively short and consistent with an announcement rather than a full financial report. The document does not contain full financial statements or detailed analysis but rather announces the earnings results and provides supplementary data. According to the classification rules, initial announcements of quarterly or periodical financial results (key highlights only) correspond to an Earnings Release (ER). Therefore, this document should be classified as an Earnings Release (ER).
2008-07-15 English
PRIMARY DOCUMENT
Director's Dealing
2008-07-02 English
PRIMARY DOCUMENT
Director's Dealing
2008-07-02 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.